H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.
Yu-Chuan ShenHui-Ching HsuTzu-Min LinYu-Sheng ChangLi-Fang HuLung-Fang ChenSheng-Hong LinPei-I KuoWei-Sheng ChenYi-Chun LinJin-Hua ChenYu-Chih LiangChi-Ching ChangPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
AH use may reduce the risk for HCC among patients with HBV, HCV, or dual infection in a dose-dependent manner. Further mechanistic research is needed.